Dr. Eva Keilhauer

Dr. Eva Keilhauer studied pharmaceutical sciences at the Ludwig-Maximilians-Universität in Munich, and later specialized on investigating protein-protein interactions by mass spectrometry-based proteomics during her PhD at the Max-Planck institute of Biochemistry.

She joined Coriolis in 2017 as a scientist, working in the operative team for several years, supporting and leading various formulation development projects.

Since 2022, Dr. Keilhauer is a member of the business development team, where she continues to apply her knowledge in formulation development to help clients tackle their specific challenges.